Patrick Hermann

7.0k total citations · 1 hit paper
50 papers, 4.8k citations indexed

About

Patrick Hermann is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Patrick Hermann has authored 50 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 26 papers in Molecular Biology and 9 papers in Cancer Research. Recurrent topics in Patrick Hermann's work include Cancer Cells and Metastasis (25 papers), Pancreatic and Hepatic Oncology Research (22 papers) and Epigenetics and DNA Methylation (6 papers). Patrick Hermann is often cited by papers focused on Cancer Cells and Metastasis (25 papers), Pancreatic and Hepatic Oncology Research (22 papers) and Epigenetics and DNA Methylation (6 papers). Patrick Hermann collaborates with scholars based in Germany, Spain and United Kingdom. Patrick Hermann's co-authors include Christopher Heeschen, Stephan Huber, Alexandra Aicher, Joachim W. Ellwart, Christiane J. Bruns, Markus Guba, Tanja Herrler, Bruno Sáinz, Enza Lonardo and M Mueller and has published in prestigious journals such as Nature Communications, Gastroenterology and PLoS ONE.

In The Last Decade

Patrick Hermann

50 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Distinct Populations of Cancer Stem Cells Determine Tumor Growth and Metastatic Activity in Human Pancreatic Cancer

2007 2.2k citations Patrick Hermann, Stephan Huber et al. Cell stem cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Patrick Hermann Germany	27	3.4k	2.5k	1.3k	575	547	50	4.8k
Scott J. Dylla United States	17	2.7k 0.8×	2.5k 1.0×	951 0.7×	373 0.6×	305 0.6×	36	4.7k
Yusuke Shiozawa United States	40	2.4k 0.7×	1.8k 0.7×	999 0.8×	818 1.4×	442 0.8×	103	4.9k
Sonja Loges Germany	35	1.9k 0.5×	2.7k 1.1×	1.4k 1.1×	926 1.6×	293 0.5×	98	5.0k
Agnieszka E. Gorska United States	31	3.0k 0.9×	3.2k 1.3×	799 0.6×	1.3k 2.3×	304 0.6×	48	5.5k
Sachie Hiratsuka Japan	18	2.2k 0.6×	3.2k 1.3×	1.6k 1.2×	1.4k 2.5×	249 0.5×	24	5.4k
Robert W. Cho United States	8	2.9k 0.8×	2.5k 1.0×	1.6k 1.3×	296 0.5×	153 0.3×	9	4.3k
Rizwan Naeem United States	8	2.0k 0.6×	1.7k 0.7×	928 0.7×	774 1.3×	199 0.4×	10	3.5k
Gilbert Spizzo Austria	29	1.7k 0.5×	2.1k 0.8×	723 0.6×	336 0.6×	356 0.7×	70	3.8k
Gerald Wulf Germany	32	1.9k 0.6×	2.9k 1.1×	849 0.7×	819 1.4×	531 1.0×	152	5.3k
Brett M. Hall United States	22	2.1k 0.6×	2.0k 0.8×	1.0k 0.8×	698 1.2×	528 1.0×	43	4.7k

Countries citing papers authored by Patrick Hermann

Since Specialization

Citations

This map shows the geographic impact of Patrick Hermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Hermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Hermann more than expected).

Fields of papers citing papers by Patrick Hermann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Hermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Hermann. The network helps show where Patrick Hermann may publish in the future.

Co-authorship network of co-authors of Patrick Hermann

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Hermann. A scholar is included among the top collaborators of Patrick Hermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Hermann. Patrick Hermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hermann, Patrick, et al.. (2022). 93P Migrating cancer stem cell elimination by disrupting tumor-stroma crosstalk using CXCR4 targeting human endogenous peptides in PDAC. Annals of Oncology. 33. S1412–S1412. 1 indexed citations

Martín-Hijano, Laura, et al.. (2021). The CXCL12 Crossroads in Cancer Stem Cells and Their Niche. Cancers. 13(3). 469–469. 41 indexed citations

Steiger, Katja, et al.. (2021). Deletion of NEMO Inhibits EMT and Reduces Metastasis in KPC Mice. Cancers. 13(18). 4541–4541. 4 indexed citations

Valle, Sandra, Sonia Alcalá, Laura Martín-Hijano, et al.. (2020). Exploiting oxidative phosphorylation to promote the stem and immunoevasive properties of pancreatic cancer stem cells. Nature Communications. 11(1). 5265–5265. 91 indexed citations

Walter, Karolin, Marija Trajkovic‐Arsic, Ana Hidalgo‐Sastre, et al.. (2019). MEK Inhibition Targets Cancer Stem Cells and Impedes Migration of Pancreatic Cancer CellsIn VitroandIn Vivo. Stem Cells International. 2019. 1–11. 12 indexed citations

Hermann, Patrick & Bruno Sáinz. (2018). Pancreatic cancer stem cells: A state or an entity?. Seminars in Cancer Biology. 53. 223–231. 76 indexed citations

Seufferlein, Thomas, et al.. (2018). IgG4-Related Diseases in the Gastrointestinal Tract: Clinical Presentation, Diagnosis and Treatment Challenges. Digestion. 100(1). 1–14. 9 indexed citations

Hann, Alexander, et al.. (2018). Chemotherapeutic agents eligible for prior dosing in pancreatic cancer patients requiring hemodialysis: a systematic review. Clinical Nephrology. 90(2). 125–141. 7 indexed citations

Perkhofer, Lukas, Karolin Walter, Ivan G. Costa, et al.. (2016). Tbx3 fosters pancreatic cancer growth by increased angiogenesis and activin/nodal-dependent induction of stemness. Stem Cell Research. 17(2). 367–378. 29 indexed citations

10.

Müller, Martin C., Patrick Hermann, Stefan Liebau, et al.. (2016). The role of pluripotency factors to drive stemness in gastrointestinal cancer. Stem Cell Research. 16(2). 349–357. 72 indexed citations

11.

Sáinz, Bruno, Sonia Alcalá, Elena García, et al.. (2015). Microenvironmental hCAP-18/LL-37 promotes pancreatic ductal adenocarcinoma by activating its cancer stem cell compartment. Gut. 64(12). 1921–1935. 105 indexed citations

12.

Hermann, Patrick, Sara Maria David Trabulo, Bruno Sáinz, et al.. (2013). Multimodal Treatment Eliminates Cancer Stem Cells and Leads to Long-Term Survival in Primary Human Pancreatic Cancer Tissue Xenografts. PLoS ONE. 8(6). e66371–e66371. 31 indexed citations

13.

Lonardo, Enza, Patrick Hermann, M Mueller, et al.. (2012). Nodal/Activin Signaling Drives Self-Renewal and Tumorigenicity of Pancreatic Cancer Stem Cells and Provides a Target for Combined Drug Therapy. Cell stem cell. 10(1). 104–104. 15 indexed citations

14.

Saif, Jaimy, Theresa Schwarz, David Chau, et al.. (2010). Combination of Injectable Multiple Growth Factor–Releasing Scaffolds and Cell Therapy as an Advanced Modality to Enhance Tissue Neovascularization. Arteriosclerosis Thrombosis and Vascular Biology. 30(10). 1897–1904. 64 indexed citations

15.

Lonardo, Enza, Patrick Hermann, & Christopher Heeschen. (2010). Pancreatic cancer stem cells – update and future perspectives. Molecular Oncology. 4(5). 431–442. 71 indexed citations

16.

Hermann, Patrick, Sonu Bhaskar, Michele Cioffi, & Christopher Heeschen. (2010). Cancer stem cells in solid tumors. Seminars in Cancer Biology. 20(2). 77–84. 158 indexed citations

17.

Herrler, Tanja, Simon F. Leicht, Stephan Huber, et al.. (2009). Prostaglandin E Positively Modulates Endothelial Progenitor Cell Homeostasis: An Advanced Treatment Modality for Autologous Cell Therapy. Journal of Vascular Research. 46(4). 333–346. 14 indexed citations

18.

Hermann, Patrick, M Mueller, & Christopher Heeschen. (2009). Pancreatic cancer stem cells – insights and perspectives. Expert Opinion on Biological Therapy. 9(10). 1271–1278. 31 indexed citations

19.

Hermann, Patrick, Stephan Huber, & Christopher Heeschen. (2008). Metastatic cancer stem cells: A new target for anti-cancer therapy?. Cell Cycle. 7(2). 188–193. 67 indexed citations

20.

Huber, Stephan, Christiane J. Bruns, G. Schmid, et al.. (2007). Inhibition of the mammalian target of rapamycin impedes lymphangiogenesis. Kidney International. 71(8). 771–777. 166 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact